Doctor profile · Federal record
Dr. KATE NEMECEK, PA-C
Physician Assistant · Medical Physician Assistant · BREA, CA
- NPI 1326596602
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
955 W IMPERIAL HWY STE 110
BREA, CA 928213814
(714) 449-6900 - Additional location
-
13965 N. 75th Avenue
Peoria, AZ 853816097
(608) 843-2991
fax (608) 978-1226
Credentials & registration
- NPI registered
- September 2016 — 10 yrs on file
- Profile last updated
- November 9, 2021
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- California #57391 · Arizona #6458
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326596602. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
76
Distinct HCPCS
3
Medicare allowed
$7,239
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 41 | 33 | $84 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 22 | 22 | $103 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 13 | 12 | $118 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 79. This provider delivers 1.0× the peer median.Open Payments
Industry payments received
All-time total
$1,211
Transactions
69
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 16 | $235.52 | |
| Regeneron Healthcare Solutions, Inc. | 16 | $219.70 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $202.00 | |
| AstraZeneca Pharmaceuticals LP | 4 | $151.53 | |
| Lilly USA, LLC | 3 | $58.66 | |
| Grifols USA, LLC | 2 | $56.80 | |
| BioCryst US Sales Co., LLC | 2 | $53.50 | |
| Novo Nordisk Inc | 2 | $51.73 | |
| Genentech USA, Inc. | 2 | $51.26 | |
| kaleo, Inc. | 3 | $48.94 | |
| Amgen Inc. | 2 | $47.99 | |
| GlaxoSmithKline, LLC. | 2 | $32.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
393
Patients
118
Total drug cost
$117,486
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Azelastine Hcl | Generic | 96 | 36 | $2,534 |
| Fluticasone Propionate | Generic | 67 | 26 | $1,437 |
| Epinephrine | Generic | 40 | 32 | $10,500 |
| Ipratropium Bromide | Generic | 32 | 0 | $1,063 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 29 | 12 | $1,111 |
| Montelukast Sodium | Generic | 29 | 12 | $493 |
| Levocetirizine Dihydrochloride | Generic | 27 | 0 | $670 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 17 | 0 | $7,908 |
| Xolair (Omalizumab) | Brand | 17 | 0 | $35,085 |
| Dupixent Pen (Dupilumab) | Brand | 15 | 0 | $54,055 |